MetLife, Inc. (NYSE:MET) Shares Purchased by Waldron Private Wealth LLC

Waldron Private Wealth LLC grew its stake in shares of MetLife, Inc. (NYSE:MET) by 10.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 4,875 shares of the financial services provider’s stock after buying an additional 476 shares during the quarter. Waldron Private Wealth LLC’s holdings in MetLife were worth $322,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of MET. Synovus Financial Corp lifted its position in shares of MetLife by 11.4% during the 1st quarter. Synovus Financial Corp now owns 17,847 shares of the financial services provider’s stock valued at $1,260,000 after acquiring an additional 1,829 shares during the last quarter. Brighton Jones LLC acquired a new stake in shares of MetLife during the 1st quarter valued at $225,000. Baird Financial Group Inc. lifted its position in shares of MetLife by 179.7% during the 1st quarter. Baird Financial Group Inc. now owns 540,081 shares of the financial services provider’s stock valued at $37,957,000 after acquiring an additional 346,999 shares during the last quarter. Zions Bancorporation N.A. lifted its position in shares of MetLife by 937.3% during the 1st quarter. Zions Bancorporation N.A. now owns 5,861 shares of the financial services provider’s stock valued at $412,000 after acquiring an additional 5,296 shares during the last quarter. Finally, Brown Brothers Harriman & Co. lifted its position in shares of MetLife by 114.5% during the 1st quarter. Brown Brothers Harriman & Co. now owns 3,419 shares of the financial services provider’s stock valued at $240,000 after acquiring an additional 1,825 shares during the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Trading Down 1.0 %

MetLife stock opened at $69.44 on Tuesday. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market capitalization of $50.21 billion, a price-to-earnings ratio of 37.95, a PEG ratio of 0.53 and a beta of 1.04. MetLife, Inc. has a one year low of $48.95 and a one year high of $74.68. The company’s fifty day moving average price is $70.89 and its two-hundred day moving average price is $66.62.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.02). The business had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, analysts forecast that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other MetLife news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Bill Pappas sold 27,000 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on MET shares. Wells Fargo & Company increased their price objective on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Piper Sandler increased their target price on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a report on Friday, April 5th. Morgan Stanley increased their target price on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Monday. Keefe, Bruyette & Woods increased their target price on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th. Finally, UBS Group reduced their target price on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and an average target price of $79.23.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.